-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
ZyVersa Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q4 2022 to Q1 2024.
- ZyVersa Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $2.6K, unchanged year-over-year.
- ZyVersa Therapeutics, Inc. annual Depreciation for 2023 was $10.4K, a 5.39% increase from 2022.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)